List of Tables
Table 1. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Sustained and Controlled Release Formulations Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Sustained and Controlled Release Formulations Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Sustained and Controlled Release Formulations Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Sustained and Controlled Release Formulations Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Sustained and Controlled Release Formulations Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Sustained and Controlled Release Formulations, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Product Type & Application
Table 12. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Sustained and Controlled Release Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Sustained and Controlled Release Formulations as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Sustained and Controlled Release Formulations Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2020-2025)
Table 19. Global Oral Sustained and Controlled Release Formulations Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2026-2031)
Table 21. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2020-2025)
Table 53. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2026-2031)
Table 54. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2020-2025)
Table 63. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2026-2031)
Table 64. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2026-2031)
Table 70. Humanwell Healthcare Co.,Ltd. Company Information
Table 71. Humanwell Healthcare Co.,Ltd. Description and Business Overview
Table 72. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 74. Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
Table 75. Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
Table 76. Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 79. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Qilu Pharmaceutical Co Ltd Company Information
Table 86. Qilu Pharmaceutical Co Ltd Description and Business Overview
Table 87. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product
Table 89. Qilu Pharmaceutical Co Ltd Recent Developments/Updates
Table 90. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
Table 91. Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
Table 92. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 94. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 97. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 100. PKU HealthCare Corp.,Ltd. Company Information
Table 101. PKU HealthCare Corp.,Ltd. Description and Business Overview
Table 102. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 104. PKU HealthCare Corp.,Ltd. Recent Developments/Updates
Table 105. Overseas Pharmaceuticals, Ltd. Company Information
Table 106. Overseas Pharmaceuticals, Ltd. Description and Business Overview
Table 107. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product
Table 109. Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
Table 110. Novast Laboratories (China), LTD. Company Information
Table 111. Novast Laboratories (China), LTD. Description and Business Overview
Table 112. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product
Table 114. Novast Laboratories (China), LTD. Recent Developments/Updates
Table 115. Catalent Company Information
Table 116. Catalent Description and Business Overview
Table 117. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Catalent Oral Sustained and Controlled Release Formulations Product
Table 119. Catalent Recent Developments/Updates
Table 120. AstraZeneca Plc Company Information
Table 121. AstraZeneca Plc Description and Business Overview
Table 122. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product
Table 124. AstraZeneca Plc Recent Developments/Updates
Table 125. Oakwood Labs Company Information
Table 126. Oakwood Labs Description and Business Overview
Table 127. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Oakwood Labs Oral Sustained and Controlled Release Formulations Product
Table 129. Oakwood Labs Recent Developments/Updates
Table 130. Ascendia Pharma Company Information
Table 131. Ascendia Pharma Description and Business Overview
Table 132. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product
Table 134. Ascendia Pharma Recent Developments/Updates
Table 135. Colorcon Company Information
Table 136. Colorcon Description and Business Overview
Table 137. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Colorcon Oral Sustained and Controlled Release Formulations Product
Table 139. Colorcon Recent Developments/Updates
Table 140. Pfizer Inc. Company Information
Table 141. Pfizer Inc. Description and Business Overview
Table 142. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product
Table 144. Pfizer Inc. Recent Developments/Updates
Table 145. Mylan Company Information
Table 146. Mylan Description and Business Overview
Table 147. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Mylan Oral Sustained and Controlled Release Formulations Product
Table 149. Mylan Recent Developments/Updates
Table 150. Sandoz Company Information
Table 151. Sandoz Description and Business Overview
Table 152. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sandoz Oral Sustained and Controlled Release Formulations Product
Table 154. Sandoz Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Oral Sustained and Controlled Release Formulations Distributors List
Table 158. Oral Sustained and Controlled Release Formulations Customers List
Table 159. Oral Sustained and Controlled Release Formulations Market Trends
Table 160. Oral Sustained and Controlled Release Formulations Market Drivers
Table 161. Oral Sustained and Controlled Release Formulations Market Challenges
Table 162. Oral Sustained and Controlled Release Formulations Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Sustained and Controlled Release Formulations
Figure 2. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Sustained and Controlled Release Formulations Market Share by Type: 2024 & 2031
Figure 4. Skeleton Type Product Picture
Figure 5. Membrane Controlled Type Product Picture
Figure 6. Osmotic Pump Type Product Picture
Figure 7. Global Oral Sustained and Controlled Release Formulations Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Oral Sustained and Controlled Release Formulations Market Share by Application: 2024 & 2031
Figure 9. Cardiovascular System Drugs
Figure 10. Nervous System Drugs
Figure 11. Digestive System and Metabolism
Figure 12. Other
Figure 13. Global Oral Sustained and Controlled Release Formulations Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oral Sustained and Controlled Release Formulations Market Size (2020-2031) & (US$ Million)
Figure 15. Global Oral Sustained and Controlled Release Formulations Sales (2020-2031) & (K Units)
Figure 16. Global Oral Sustained and Controlled Release Formulations Average Price (US$/Unit) & (2020-2031)
Figure 17. Oral Sustained and Controlled Release Formulations Report Years Considered
Figure 18. Oral Sustained and Controlled Release Formulations Sales Share by Manufacturers in 2024
Figure 19. Global Oral Sustained and Controlled Release Formulations Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Oral Sustained and Controlled Release Formulations Players: Market Share by Revenue in Oral Sustained and Controlled Release Formulations in 2024
Figure 21. Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Oral Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 24. North America Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 25. United States Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 28. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 29. Germany Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2020-2031)
Figure 36. China Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 44. Latin America Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Sustained and Controlled Release Formulations by Type (2020-2031)
Figure 54. Global Revenue Market Share of Oral Sustained and Controlled Release Formulations by Type (2020-2031)
Figure 55. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Oral Sustained and Controlled Release Formulations by Application (2020-2031)
Figure 57. Global Revenue Market Share of Oral Sustained and Controlled Release Formulations by Application (2020-2031)
Figure 58. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2020-2031)
Figure 59. Oral Sustained and Controlled Release Formulations Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
